Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers S > Headlines for Sharon Bio Medicine Ltd. > News item |
Sharon Bio-Medicine reduces conversion price on convertibles
By Devika Patel
Knoxville, Tenn., Dec. 8 - Sharon Bio-Medicine Ltd. said it adjusted the conversion price of its $16.5 million in foreign currency convertible bonds to Rs. 252 per share from Rs. 315 per share, effective Nov. 27.
The change was due to a price reset date scheduled for Nov. 27.
Sharon Bio-Medicine is a Mumbai, India-based pharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.